June 14, 2022 Michelle Basil c/o Haemonetics Corporation Boston, MA 02110 RE: Executive Vice President and General Counsel Retention and Transition Agreement Dear Michelle:Retention and Transition Agreement • August 10th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledAugust 10th, 2022 Company Industry JurisdictionThis Retention and Transition Agreement (this “Agreement”) sets forth the understanding between you and Haemonetics Corporation (the “Company”) regarding your continued employment as Executive Vice President and General Counsel of the Company and your planned resignation from the Company and transition. On behalf of the Board of Directors of the Company, I want to thank you for your willingness to provide continued service as Executive Vice President and General Counsel in order to ensure a seamless and successful transition to the next Executive Vice President and General Counsel of the Company.
November 8, 2021 William P. Burke Address on file with the Company RE: CFO Retention and Transition Agreement Dear Bill:Retention and Transition Agreement • February 8th, 2022 • Haemonetics Corp • Surgical & medical instruments & apparatus
Contract Type FiledFebruary 8th, 2022 Company IndustryThis Retention and Transition Agreement (this “Agreement”) sets forth the understanding between you and Haemonetics Corporation (the “Company”) regarding your continued employment as Chief Financial Officer of the Company and your planned retirement from the Company and transition. On behalf of the Board of Directors of the Company, I want to thank you for your willingness to provide continued service as Chief Financial Officer and then in the role of Special Advisor as provided in this Agreement in order to ensure a seamless and successful transition to the next Chief Financial Officer of the Company.